Keyphrases
Chronic Myeloid Leukemia
100%
Thromboxane A2 Receptor
100%
K562 Leukemia Cells
100%
Thromboxane A2 (TXA2)
42%
Receptor-mediated
28%
Plasma Membrane
28%
125I
28%
Incubation
28%
K562
28%
SQ29548
28%
Binding Site
14%
Cell Surface Receptor
14%
Methyl
14%
Receptor Downregulation
14%
Receptor Density
14%
Membrane Binding
14%
Desensitization
14%
Ligand Binding
14%
Amino
14%
Platelets
14%
Biologic Response
14%
Culture Media
14%
Co-incubation
14%
Intracellular Calcium
14%
Human Platelets
14%
Receptor Affinity
14%
Carbonyl
14%
Receptor Internalization
14%
Calcium Flux
14%
Leukemic Cells
14%
Phenyl
14%
Calcium Transient
14%
K562 Cells
14%
Hydrazino
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
Thromboxane A2 Receptor
100%
Receptor
57%
15 Hydroxy 9alpha,11alpha Epoxymethanoprosta 5,13 Dienoic Acid
42%
Iodine-125
28%
Thromboxane A2
28%
Desensitization
14%
Binding Site
14%
Thromboxane A2 Receptor Blocking Agent
14%